Analyse
Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation
#IPO ×
Analyse
21 sept. 2026•1 min de lecture
BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process
BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.
Analyse
30 août 2026•1 min de lecture
Sky Labs Announces KOSDAQ IPO, Plans to Offer 2 Million Shares
Sky Labs submitted its securities filing to the Financial Services Commission and began its public offering, targeting 2 million shares at KRW 13,000‑16,000 each.